112 related articles for article (PubMed ID: 27784384)
1. [Thrombocytopoietic Efficacy of Pegylated Recombinant Human Interleukin-11 Mutein in Myelosuppressed Mice].
Ma SS; Ho SH; Wang HL; Nie LY; Xu SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1511-1517. PubMed ID: 27784384
[TBL] [Abstract][Full Text] [Related]
2. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.
Shibuya K; Akahori H; Takahashi K; Tahara E; Kato T; Miyazaki H
Blood; 1998 Jan; 91(1):37-45. PubMed ID: 9414267
[TBL] [Abstract][Full Text] [Related]
3. Further examination of various administration protocols of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia in myelosuppressed mice.
Akahori H; Ozai M; Ida M; Shibuya K; Kato T; Miyazaki H
Ther Apher; 1998 Feb; 2(1):58-64. PubMed ID: 10227790
[TBL] [Abstract][Full Text] [Related]
4. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.
Akahori H; Shibuya K; Ozai M; Ida M; Kabaya K; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):678-89. PubMed ID: 8948025
[TBL] [Abstract][Full Text] [Related]
5. The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice.
Ulich TR; del Castillo J; Senaldi G; Cheung E; Roskos L; Young J; Molineux G; Guo J; Schoemperlen J; Munyakazi L; Murphy-Filkins R; Tarpley JE; Toombs CF; Kaufman S; Yin S; Nelson AG; Nichol JL; Sheridan WP
Exp Hematol; 1999 Jan; 27(1):117-30. PubMed ID: 9923450
[TBL] [Abstract][Full Text] [Related]
6. A schedule of recombinant Mpl ligand highly effective at preventing lethal myelosuppression in mice given carboplatin and radiation.
Abushullaih BA; Pestina TI; Srivastava DK; Jackson CW; Daw NC
Exp Hematol; 2001 Dec; 29(12):1425-31. PubMed ID: 11750101
[TBL] [Abstract][Full Text] [Related]
7. Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice.
Kabaya K; Shibuya K; Torii Y; Nitta Y; Ida M; Akahori H; Kato T; Kusaka M; Miyazaki H
Bone Marrow Transplant; 1996 Dec; 18(6):1035-41. PubMed ID: 8971370
[TBL] [Abstract][Full Text] [Related]
8. Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression.
Coleman D; Fairchild D; Schindler-Horvat J; Munyakazi L; Neumann TA
Toxicol Sci; 1998 Sep; 45(1):77-87. PubMed ID: 9848114
[TBL] [Abstract][Full Text] [Related]
9. [Radioprotective effect of rmIL-12 on mice irradiated by γ-ray].
Wang L; Zhai RR; Pang ZX; Zhang C; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1027-31. PubMed ID: 23998606
[TBL] [Abstract][Full Text] [Related]
10. Romiplostim (Nplate
Bunin DI; Bakke J; Green CE; Javitz HS; Fielden M; Chang PY
Int J Radiat Biol; 2020 Jan; 96(1):145-154. PubMed ID: 31021662
[No Abstract] [Full Text] [Related]
11. The haemopoietic effects of thrombopoietin administered post-myelosuppressive carboplatin therapy compared to either pre- and post- or pre-chemotherapy.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Kulczyk ST; Cairo MS
Br J Haematol; 1998 Aug; 102(3):775-82. PubMed ID: 9722306
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetic and pharmacodynamic properties of site-specific pegylated genetically modified recombinant human interleukin-11 in normal and thrombocytopenic monkeys.
Ma SS; Ho SH; Ma SY; Li YJ; Li KT; Tang XC; Zhao GR; Xu SS
Eur J Pharm Biopharm; 2017 Oct; 119():185-191. PubMed ID: 28596035
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
[TBL] [Abstract][Full Text] [Related]
14. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
[TBL] [Abstract][Full Text] [Related]
16. A highly enhanced thrombopoietic activity by monomethoxy polyethylene glycol-modified recombinant human interleukin-6.
Inoue H; Kadoya T; Kabaya K; Tachibana K; Nishi N; Sato M; Ohsawa M; Mikayama T; Mori KJ
J Lab Clin Med; 1994 Oct; 124(4):529-36. PubMed ID: 7930877
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
Tang G; Wang XM; Meng JX; Luan CL; Chen JF; Wu YQ; Zhang XN; He ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):234-238. PubMed ID: 29397850
[TBL] [Abstract][Full Text] [Related]
18. [Promotion of Thrombopoiesis by rhIL-11 in Normal and Myelosuppressed Mice].
Zuo C; Xu M; Wang Y; Yi H; Feng Y; Li T; Liu X; Huang X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Mar; 8(1):24-30. PubMed ID: 12578714
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons.
Andrews RG; Winkler A; Myerson D; Briddell RA; Knitter GH; McNiece IK; Hunt P
Stem Cells; 1996 Nov; 14(6):661-77. PubMed ID: 8948024
[TBL] [Abstract][Full Text] [Related]
20. Marked improvement of thrombocytopenia in a murine model of idiopathic thrombocytopenic purpura by pegylated recombinant human megakaryocyte growth and development factor.
Shibuya K; Kuwaki T; Tahara E; Yuki C; Akahori H; Kato T; Miyazaki H
Exp Hematol; 2002 Oct; 30(10):1185-92. PubMed ID: 12384150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
